FDA Drug Application (021416) for RYTHMOL SR by GLAXOSMITHKLINE LLC

Back to FDA Applications sponsored by GLAXOSMITHKLINE LLC

Application Number021416
Product Number001
FormCAPSULE, EXTENDED RELEASE;ORAL
Dosage225MG
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AB Products meeting necessary bioequivalence requirements
Reference Drug
Drug NameRYTHMOL SR
Active IngredientPROPAFENONE HYDROCHLORIDE

Active IngredientCount
List of drugs with Active Ingredient PROPAFENONE HYDROCHLORIDE3


Back to FDA Applications sponsored by GLAXOSMITHKLINE LLC